TYRX Receives FDA Clearance for Use of Antibacterial Envelope With Spinal Cord Neuromodulators

TYRX announced that it has received FDA clearance for marketing the AIGISRx N Antibacterial Envelope for use with spinal cord neuromodulators.

Advertisement

This comes soon after FDA clearance of the envelope for use with vagus nerve stimulators.

 

The AIGISRx N Antibacterial Envelope is intended to hold a spinal cord neuromodulator or vagus nerve stimulator securely in place to provide a stable environment when implanted in the body.

More Articles on Supply Chain:

5 Ways Materials Management Information Systems Can Improve Surgery Center Supply Chain
Mazor Robotics’ Sells Renaissance Spine System to Lawnwood Regional Medical Center
Alphatec Spine Posts $14.5M Q3 Loss After PurGen Device Discontinuation

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.